Home › Funds › LMR Partners LLP › GSK

LMR Partners LLP position in GSK

GSK PLC · Health Care

LMR Partners LLP reported holding 980,479 shares of GSK (GSK PLC) in its Q2 2026 13F filing — a position valued at US$51.4M, representing 0.45% of its reported portfolio and ranking #35 among its reported holdings. LMR Partners LLP has disclosed GSK holdings in 10 of the last 10 reported quarters, going back to Q1 2024.

Latest position (Q2 2026)980.48K sh
Reported value held$51.40M
Portfolio Weight0.45%
First reportedQ1 2024
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How LMR Partners LLP's GSK position evolved

LMR Partners LLP first disclosed a stake in GSK in Q1 2024 at 1,232,283 shares (US$52.8M). The position peaked in Q2 2024 at 3,331,458 shares, worth US$128.3M. Across 10 filings, LMR Partners LLP increased the stake 2 time(s), trimmed it 4 time(s) and left it unchanged 3 time(s). The most recent filing (Q2 2026) shows 980,479 shares valued at US$51.4M. Notable position changes include a 170% increase in Q2 2024 (shares rose 6% over the following quarter), a 91% trim in Q2 2025 (shares rose 12% over the following quarter), a 3918% increase in Q1 2026 (shares fell 5% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2024 1.23M $52.83M New
Q2 2024 3.33M $128.26M Add
Q3 2024 2.02M $82.54M Reduce
Q4 2024 384.30K $13.00M Reduce
Q1 2025 384.30K $14.89M Hold
Q2 2025 32.70K $1.26M Reduce
Q3 2025 24.40K $1.05M Reduce
Q4 2025 24.40K $1.20M Hold
Q1 2026 980.48K $54.11M Add
Q2 2026 980.48K $51.40M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GSK and 13F data

GSK (GSK PLC) is a Health Care company. 23 other funds we track also report a position in GSK — the largest reported positions include Dodge & Cox (US$2.53B), DODGE & COX (US$2.53B), PRIMECAP MANAGEMENT CO/CA/ (US$1.32B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GSK

All GSK fund holders →

FAQ

How long has LMR Partners LLP held GSK?

LMR Partners LLP has disclosed GSK holdings in 10 of the last 10 reported quarters, going back to Q1 2024.

What is LMR Partners LLP's current position in GSK?

As of Q2 2026, LMR Partners LLP holds 980.48K shares of GSK (GSK PLC), valued at $51.40M, representing 0.45% of its reported portfolio and ranking #35.

Has LMR Partners LLP been buying or selling GSK?

In the latest 13F filing (Q2 2026), LMR Partners LLP held unchanged its position in GSK. The position peaked in Q2 2024 at 3.33M shares.

Which other funds hold GSK?

Other major institutional holders of GSK include Dodge & Cox, DODGE & COX, PRIMECAP MANAGEMENT CO/CA/, among 23 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.